Vol 13, No 10 (October 31, 2024): Translational Lung Cancer Research

Expert Consensus

Systems mapping: a novel approach to national lung cancer screening implementation in Australia
Sandra Marjanovic, Andrew Page, Emily Stone, Danielle J. Currie, Nicole M. Rankin, Renelle Myers, Fraser Brims, Neal Navani, Kate A. McBride

Original Article

Adding immune checkpoint inhibitors to chemotherapy confers modest survival benefit in patients with small cell lung cancer and brain metastases: a retrospective analysis
Baishen Zhang, Jing Chen, Hui Yu, Meichen Li, Likun Chen
Exploring immunotherapy efficacy in non-small cell lung cancer patients with BRAF mutations: a case series and literature review
Izabela Chmielewska, Paweł Krawczyk, Magdalena Wójcik-Superczyńska, Anna Grenda, Michał Gil, Katarzyna Stencel, Robert Kieszko, Tomasz Jankowski, Janusz Milanowski
Efficacy and safety of radial probe endobronchial ultrasound-guided biopsy for peripheral lung lesions in chronic obstructive pulmonary disease patients
Young Seok Lee, Kyung Soo Hong, Jong Geol Jang, June Hong Ahn
Detailed characterization of combination treatment with MET inhibitor plus EGFR inhibitor in EGFR-mutant and MET-amplified non-small cell lung cancer
Youngjoo Lee, Seog-Yun Park, Geon Kook Lee, Hyun-Ju Lim, Yu-Ra Choi, Jaemin Kim, Ji-Youn Han
Exposure-lag response of surface net solar radiation on lung cancer incidence: a global time-series analysis
Xuanzhuang Lu, Runchen Wang, Jianfu Li, Shixuan Lyu, Jianrong Zhang, Qixia Wang, Wenhao Chi, Ran Zhong, Chao Chen, Xinjian Wu, Ruiyu Hu, Zhixuan You, Yuqi Mai, Songlin Xie, Jiayu Lin, Boyu Zheng, Qiu Zhong, Jianxing He, Wenhua Liang
Triple-targeted therapy of dabrafenib, trametinib, and osimertinib for the treatment of the acquired BRAF V600E mutation after progression on EGFR-tyrosine kinase inhibitors in advanced EGFR-mutated non-small cell lung cancer patients
Cheng-Di Weng, Ke-Jun Liu, Shi Jin, Jun-Wei Su, Yi-Hui Yao, Cheng-Zhi Zhou, Yu-Fa Li, Ze-Xin Chen, Hua-Jun Chen, Yan-Ying Li, Ke-Jing Tang, Jin-Ji Yang
Insights into sex differences in perioperative outcomes of non-small cell lung cancer patients
Quan Zheng, Jian Zhou, Yuanjin Zhang, Tengyong Wang, Dongsheng Wu, Qiang Pu, Jiandong Mei, Hu Liao, Lunxu Liu
Electromagnetic navigation bronchoscopy-guided preoperative lung nodule localization in video-assisted thoracic surgery (VATS): a learning curve analysis
Menghua Xue, Ke Lan, Xiaolong Yan, Tao Jiang, Xiaoping Wang, Feng Tian, Yunfeng Ni, Jinbo Zhao
Impact of docetaxel plus ramucirumab therapy on interstitial lung disease in recurrent advanced non-small cell lung cancer patients
Noriyuki Ebi, Hiroyuki Inoue, Yuta Fujimoto, Maiya Chen, Rei Sanai, Natsumi Kushima, Yusuke Osaki, Takato Ikeda, Akira Nakao, Yuki Shundo, Toyoshi Yanagihara, Naoki Hamada, Masaki Fujita
Predicting prognosis in patients with stage IA lung adenocarcinoma with a micropapillary component using a nomogram based on computed tomography radiomics and clinicopathologic factors: a retrospective analysis
Ying Li, Junfeng Zhao, Ruyue Li, Xiujing Yao, Xue Dong, Ying Zhao, Zhongshuo Xia, Yali Xu, Yintao Li
Prognostic significance of bone metastasis and clinical value of bone radiotherapy in metastatic non-small cell lung cancer receiving PD-1/PD-L1 inhibitors: results from a multicenter, prospective, observational study
Huiling Dong, Aihua Lan, Jie Gao, Yulin An, Li Chu, Xi Yang, Xiao Chu, Jie Hu, Qian Chu, Jianjiao Ni, Zhengfei Zhu
A nomogram for predicting invasiveness of lung adenocarcinoma manifesting as ground-glass nodules based on follow-up CT imaging
Hanting Li, Qinyue Luo, Yuting Zheng, Chengyu Ding, Jinrong Yang, Leqing Chen, Xiaoqing Liu, Tingting Guo, Jun Fan, Xiaoyu Han, Heshui Shi
Inflammation, tertiary lymphoid structures, and lung cancer: a bibliometric analysis
Xiwen Liu, Huiting Liu, Linchong Huang, Lixuan Lin, Qi Cai, Yang Xiang, Zengfu Liu, Shuxin Zeng, Jianxing He, Wenhua Liang
Response to platinum-based therapies in second-line after immunotherapy in advanced or metastatic non-small-cell lung cancer PD-L1 ≥50%
Alejandro Olivares-Hernández, Luis Posado-Domínguez, Juan Carlos Redondo-González, Laura Corvo-Félix, Lorena Bellido Hernández, Emilio Fonseca-Sánchez, Edel del Barco-Morillo
SWItch/Sucrose Nonfermentable complex-deficient pulmonary neoplasms: clinicopathologic characteristics and outcomes to radiotherapy and immunotherapy
Yu Gu, Songtao Lai, Juan Yang, Junhua Zhang, Xingwen Fan, Qiang Zheng
Phase II study of ramucirumab and docetaxel for previously platinum-treated patients with non-small cell lung cancer and malignant pleural effusion (PLEURAM study)
Shinnosuke Takemoto, Minoru Fukuda, Ryosuke Ogata, Hiroaki Senju, Nanae Sugasaki, Katsumi Nakatomi, Hiromi Tomono, Takayuki Suyama, Eisuke Sasaki, Midori Matsuo, Kazumasa Akagi, Fumiko Hayashi, Yosuke Dotsu, Sawana Ono, Noritaka Honda, Hirokazu Taniguchi, Hiroshi Gyotoku, Takaya Ikeda, Seiji Nagashima, Hiroshi Soda, Akitoshi Kinoshita, Hiroshi Mukae
Microbiota modulate immune repertories in lung adenocarcinoma via microbiota-immunity interactive network
Peng Liang, Qianxi Chen, Xiaoping Chen, Xiaolin Zhang, Yizhen Xiao, Guangni Liang, Ming Liu, Jianxing He, Wenhua Liang, Yufeng Liang, Bo Chen
Construction of a lung cancer 3D culture model based on alginate/gelatin micro-beads for drug evaluation
Ziying Zhao, Xiaoqing Feng, Huijuan Wu, Shuisheng Chen, Changsong Ma, Ziyun Guan, Luwen Lei, Kejing Tang, Xiao Chen, Yong Dong, Yubo Tang
Necroptosis-related lncRNAs: biomarkers for predicting prognosis and immune response in lung adenocarcinoma
Chunxuan Lin, Kunpeng Lin, Xiaochun Lin, Hai Yuan, Yingying Zhang, Zhijun Xie, Yong Dai, Luhao Liu, Yoshihisa Shimada, Taichiro Goto, Katsuhiro Okuda, Taisheng Liu, Chenggong Wei
Role of CENPL, DARS2, and PAICS in determining the prognosis of patients with lung adenocarcinoma
Rongjian Xu, Fengyi Han, Yandong Zhao, Ao Liu, Ning An, Baogang Wang, Patrick Zardo, José Sanz-Santos, Aimée J. P. M. Franssen, Erik R. de Loos, Min Zhao
DeepGR: a deep-learning prognostic model based on glycolytic radiomics for non-small cell lung cancer
Tingting Fu, Peipei Yan, Lina Zhou, Zhihua Lu, Ao Liu, Xiao Ding, Jacopo Vannucci, Paul Hofman, Andrzej Swierniak, Edyta Szurowska, Junjun Zhang, Shicheng Li
The time-to-surgery interval and its effect on pathological response after neoadjuvant chemoimmunotherapy in non-small cell lung cancer: a retrospective cohort study
Shuai-Dong Lin, Chang-Yong Tong, Dan-Dong Huang, Antonio Rossi, Hiroyuki Adachi, Miao Miao, Wen-Xin Zheng, Jing Guo
Blood biomarkers to predict the efficacy of neoadjuvant chemo-immunotherapy in non-small cell lung cancer patients
Yang Pan, Xuanhong Jin, Jiandong Hong, Yuxia Wang, Haoting Xu, Jingwei Lin, Yan Zhang, Kailai Yin, Jinhao Zhang, Kentaro Inamura, Dujiang Liu, Feng Li, Jian Zeng
Association of concomitant H1 antihistamine and immune checkpoint inhibitor therapy on survival outcome and safety in patients with advanced primary lung cancer: a cohort study
Wei-Hong Zhang, Bing-Xue Li, Chen-Xi Ma, Jian Wang, Fan Yang, Yan-Juan Xiong, Shu-Zhan Li, Jia-Li Zhang, Wei-Jiao Du, Zhen-Zhen Hui, Meng Shen, Li Zhou, Run-Mei Li, Xiao Tian, Ying Han, Bao-Zhu Ren, Yoshinobu Ichiki, Sang Chul Lee, Xin-Wei Zhang, Shui Cao, Xiu-Bao Ren, Liang Liu
Clinical, pathological, and computed tomography morphological features of lung cancer with spread through air spaces
Xiuming Zhang, Wei Qiao, Jiannan Shen, Qianlai Jiang, Chunhan Pan, Yunnong Wang, Joanna Bidzińska, Feng Dai, Lei Zhang